Testing effectiveness (Phase 2)Active Not RecruitingNCT07105384
What this trial is testing
Quantification Tools for a Novel Tau PET Marker in a Rare Neurological Disease: 18F-PI-2620 in Progressive Supranuclear Palsy
Who this might be right for
Parkinson Disease
Fundacion Clinic per a la Recerca Biomédica 66